Inhibitory effect of ibuprofen on tumor survival and angiogenesis in gastric cancer cell

Gastric Cancer: Current Status of Diagnosis and Treatment

(2013) Tsunehiro Takahashi et al.   Cancers

Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations

(2012) Patrizia Bonelli et al.   International Journal of Nanomedicine

The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer

(2011) Byung Ik Jang et al.   Gut and Liver

Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma

(2010) Junko Matsuoka et al.   JOURNAL OF SURGICAL RESEARCH

Changes in the gene expression profile of gastric cancer cells in response to ibuprofen: a gene pathway analysis

(2010) P Bonelli et al.   PHARMACOGENOMICS JOURNAL

Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs

(2009) Eva Lincová et al.   BIOCHEMICAL PHARMACOLOGY

Ibuprofen and hydrogel-released ibuprofen in the reduction of inflammation-induced migration in melanoma cells

(2009) M. Redpath et al.   BRITISH JOURNAL OF DERMATOLOGY

p53 is important for the anti-proliferative effect of ibuprofen in colon carcinoma cells

(2007) Astrid Janssen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS